Abstract

Abstract Aim We studied the inflammatory status, suggested by high sensitivity C-reactive protein (hsCRP) in patients with rheumatic mitral stenosis (MS) before, immediately after, and 1-month after balloon mitral valvuloplasty (BMV). Methods and results We studied 31 BMV candidates [35.6 ± 12.8 years, 20 (65%) females, and 9 (29%) had atrial fibrillation rhythm]. Mitral valve area (MVA) and hsCRP were measured before, immediately after BMV, and 1 month after BMV in 13 patients. In addition, hsCRP was measured in 15 controls. hsCRP was significantly higher in MS patients than control, significantly increased after BMV, and dropped 1 month after BMV to values comparable to basal but still higher than normal. hsCRP showed a trend for correlation with MVA after BMV ( r = 0.384, p = 0.07), and the absolute increase in MVA (d-MVA) correlated significantly with the absolute increase in hsCRP (d-CRP) ( r = 0.523, p = 0.01). 21 patients had successful BMV and 10 patients had unsuccessful BMV. The increase in hsCRP post compared to pre-BMV was attenuated in patients with unsuccessful BMV, and receiver operator characteristic curve suggested that hsCRP >3.6 before BMV and d-CRP Conclusion Inflammatory pathogenesis of rheumatic fever, suggested by hsCRP, seems fixed both before, and after BMV. A basal increase in hsCRP before BMV is related to BMV success and an acute increase immediately after BMV seems related to trauma of balloon dilatations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.